Vir Biotechnology VIR Balance Sheet (2018-2026)

NASDAQ VIR
$13.30 -0.35 (-2.53%)
As of: Nov 10, 2026 · 2:11 PM EST
Reported Financials

Vir Biotechnology Quarterly Balance Sheet

Periods 33 quarters
Latest Sep 2026

Vir Biotechnology reported total assets of $1111.86M and total liabilities of $215.82M for the quarter ended Sep 2026, up 9.1% year over year. This balance sheet covers 33 quarters of results from Sep 2018 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Balance SheetBalance Sheet Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
347.82M812.36M1,505.18M963.74M848.63M824.91M666.95M452.10M241.58M160.71M296.86M168.35M222.95M273.57M211.10M170.08M232.19M274.16M278.73M218.87M
Short-term InvestmentsInvestments (Current)
217.18M399.83M654.11M1,359.95M1,521.52M1,406.58M1,166.95M1,233.63M1,270.98M985.13M849.83M740.61M678.05M517.37M387.65M327.75M228.75M196.28M249.86M235.77M
Cash & Current Investments
565.00M1,212.18M2,159.30M2,323.68M2,370.15M2,231.49M1,833.90M1,685.73M1,512.56M1,145.84M1,146.70M908.96M901.00M790.94M598.75M497.83M460.94M470.44M528.59M454.64M
Receivables - NetNet Receivables
773.08M1,223.16M7.00M
Receivables - OtherOther Receivables
Receivables
773.08M1,223.16M7.00M
Prepaid Assets
73.00M69.91M72.42M54.18M104.36M97.60M85.74M59.43M52.55M50.00M40.73M43.09M47.73M42.39M41.47M36.96M45.14M44.76M39.08M47.98M
Current Assets
1,562.82M2,567.55M2,288.27M2,413.62M2,519.08M2,358.63M1,946.33M1,769.18M1,588.23M1,213.10M1,205.74M1,047.16M1,042.46M932.21M735.71M545.68M514.08M522.99M573.74M508.27M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net)
42.83M65.58M85.14M100.23M105.61M103.76M104.13M99.31M96.02M92.48M66.06M64.79M63.18M61.68M60.80M58.20M55.62M53.16M50.43M47.77M
Long-Term Investments
201.39M103.54M97.59M34.10M23.93M49.19M52.36M39.62M105.28M359.72M279.99M271.50M190.02M218.14M286.10M304.21M314.58M332.97M475.02M442.93M
Goodwill
16.94M16.94M16.94M16.94M16.94M16.94M16.94M16.94M16.94M16.94M16.94M16.94M16.94M16.94M16.94M16.94M16.94M16.94M16.94M16.94M
Intangibles
33.29M33.15M33.02M32.89M32.76M32.62M25.59M25.46M22.57M22.47M18.90M19.26M8.12M8.07M8.00M7.92M7.85M7.78M7.70M7.63M
Goodwill & Intangibles
50.22M50.09M49.96M49.83M49.69M49.56M42.53M42.39M39.50M39.40M35.84M36.20M25.06M25.01M24.94M24.86M24.79M24.71M24.64M24.57M
Other Non-Current Assets
7.01M9.04M8.35M7.28M6.66M6.74M6.74M7.06M6.45M6.43M6.37M6.38M18.42M6.27M6.96M22.94M31.66M31.00M31.59M30.32M
Non-Current Assets
391.45M319.58M330.73M282.35M283.01M307.30M297.54M275.72M330.83M580.87M463.82M451.20M356.36M375.52M456.83M473.77M488.74M502.60M641.07M603.58M
Assets
1,954.27M2,887.13M2,618.99M2,695.97M2,802.09M2,665.94M2,243.87M2,044.90M1,919.06M1,793.97M1,669.56M1,498.36M1,398.81M1,307.73M1,192.53M1,019.45M1,002.82M1,025.59M1,214.81M1,111.86M
Liabilities
Current Liabilities
Accounts Payables
6.52M10.96M10.62M2.72M6.42M12.15M12.36M3.63M6.33M7.11M4.39M7.31M5.08M3.73M12.23M6.85M9.80M5.45M17.75M11.32M
Payables
6.52M10.96M10.62M2.72M6.42M12.15M12.36M3.63M6.33M7.11M4.39M7.31M5.08M3.73M12.23M6.85M9.80M5.45M17.75M11.32M
Accumulated Expenses
236.51M577.67M354.09M282.62M489.09M455.92M197.58M146.11M104.22M72.26M75.32M94.66M98.52M104.13M82.66M68.38M83.01M68.11M77.21M69.34M
Other Accumulated Expenses
58.67M103.32M48.28M27.77M12.71M9.72M
Current Leases
Current Taxes
6.22M404.43M157.54M98.19M15.23M15.25M
Current Deferred Revenue
98.21M113.74M113.16M22.87M15.52M17.22M15.68M15.31M64.85M14.69M16.70M15.20M12.65M11.94M10.11M
Total Current Liabilities
341.24M702.36M477.87M308.20M511.03M485.29M225.62M165.05M175.41M94.07M96.41M117.16M119.66M137.29M105.00M75.22M92.82M73.56M94.96M80.66M
Non-Current Liabilities
Non-Current Deferred Revenue
3.82M5.87M4.42M54.65M53.21M53.21M53.21M53.21M1.53M1.53M9.43M
Pension
Preferred Stock Liabilities
Minority Interest
0.04M
Non-Current Deferred Tax LiabilityNon-Current Deferred Tax
18.44M18.44M18.44M18.44M3.25M3.25M
Operating Leases
133.56M132.81M130.21M126.94M123.84M121.46M117.82M114.12M111.67M109.17M95.02M93.41M90.14M88.17M93.41M91.22M89.05M86.64M84.14M81.46M
Other Non-Current Liabilities
31.06M26.64M36.05M37.88M36.05M31.93M37.02M37.43M41.74M41.85M44.46M47.06M38.63M38.45M46.65M47.49M55.68M52.63M53.22M53.70M
Total Non-Current Liabilities
491.36M859.48M630.93M508.24M688.07M663.21M396.65M332.38M287.08M204.77M191.43M210.57M209.80M225.46M198.41M175.87M181.87M160.19M179.10M162.12M
Total Liabilities
522.42M886.12M666.98M546.12M724.13M695.14M433.67M369.81M328.82M246.61M235.89M257.63M248.43M263.91M245.06M223.36M237.55M212.82M232.31M215.82M
Shareholder's Equity
Common Equity
1,431.85M2,001.01M1,952.01M2,149.86M2,077.96M1,970.80M1,810.21M1,675.09M1,590.24M1,547.36M1,433.67M1,240.73M1,150.39M1,043.82M947.47M796.10M765.28M812.77M982.49M896.04M
Liabilities and Shareholders Equity
1,954.27M2,887.13M2,618.99M2,695.97M2,802.09M2,665.94M2,243.87M2,044.90M1,919.06M1,793.97M1,669.56M1,498.36M1,398.81M1,307.73M1,192.53M1,019.45M1,002.82M1,025.59M1,214.81M1,111.86M
Retained Earnings
-138.60M380.02M303.53M478.84M377.24M236.34M41.56M-121.85M-237.82M-303.10M-441.48M-655.20M-759.78M-880.75M-991.71M-1,154.85M-1,197.77M-1,323.47M-1,243.39M-1,339.64M

Vir Biotechnology Balance Sheet API

Pull Vir Biotechnology's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=VIR&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY